267 related articles for article (PubMed ID: 23640463)
1. Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts.
Huang SK; Scruggs AM; Donaghy J; Horowitz JC; Zaslona Z; Przybranowski S; White ES; Peters-Golden M
Cell Death Dis; 2013 May; 4(5):e621. PubMed ID: 23640463
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice.
Sanders YY; Hagood JS; Liu H; Zhang W; Ambalavanan N; Thannickal VJ
Eur Respir J; 2014 May; 43(5):1448-58. PubMed ID: 24603818
[TBL] [Abstract][Full Text] [Related]
3. Effects of dynamic changes in histone acetylation and deacetylase activity on pulmonary fibrosis.
Li M; Zheng Y; Yuan H; Liu Y; Wen X
Int Immunopharmacol; 2017 Nov; 52():272-280. PubMed ID: 28961490
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibition downregulates collagen 3A1 in fibrotic lung fibroblasts.
Zhang X; Liu H; Hock T; Thannickal VJ; Sanders YY
Int J Mol Sci; 2013 Sep; 14(10):19605-17. PubMed ID: 24084714
[TBL] [Abstract][Full Text] [Related]
5. Protein Tyrosine Phosphatase-N13 Promotes Myofibroblast Resistance to Apoptosis in Idiopathic Pulmonary Fibrosis.
Bamberg A; Redente EF; Groshong SD; Tuder RM; Cool CD; Keith RC; Edelman BL; Black BP; Cosgrove GP; Wynes MW; Curran-Everett D; De Langhe S; Ortiz LA; Thorburn A; Riches DWH
Am J Respir Crit Care Med; 2018 Oct; 198(7):914-927. PubMed ID: 29727583
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.
Korfei M; Stelmaszek D; MacKenzie B; Skwarna S; Chillappagari S; Bach AC; Ruppert C; Saito S; Mahavadi P; Klepetko W; Fink L; Seeger W; Lasky JA; Pullamsetti SS; Krämer OH; Guenther A
PLoS One; 2018; 13(11):e0207915. PubMed ID: 30481203
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Regulation of Caveolin-1 Gene Expression in Lung Fibroblasts.
Sanders YY; Liu H; Scruggs AM; Duncan SR; Huang SK; Thannickal VJ
Am J Respir Cell Mol Biol; 2017 Jan; 56(1):50-61. PubMed ID: 27560128
[TBL] [Abstract][Full Text] [Related]
9. Loss of Fas signaling in fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis.
Redente EF; Chakraborty S; Sajuthi S; Black BP; Edelman BL; Seibold MA; Riches DW
JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290280
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts.
Sanders YY; Tollefsbol TO; Varisco BM; Hagood JS
Am J Respir Cell Mol Biol; 2011 Jul; 45(1):16-23. PubMed ID: 20724553
[TBL] [Abstract][Full Text] [Related]
11. Modulation of H4K16Ac levels reduces pro-fibrotic gene expression and mitigates lung fibrosis in aged mice.
Zhang X; Liu H; Zhou JQ; Krick S; Barnes JW; Thannickal VJ; Sanders YY
Theranostics; 2022; 12(2):530-541. PubMed ID: 34976199
[TBL] [Abstract][Full Text] [Related]
12. Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis.
Coward WR; Watts K; Feghali-Bostwick CA; Knox A; Pang L
Mol Cell Biol; 2009 Aug; 29(15):4325-39. PubMed ID: 19487460
[TBL] [Abstract][Full Text] [Related]
13. The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis.
Conforti F; Davies ER; Calderwood CJ; Thatcher TH; Jones MG; Smart DE; Mahajan S; Alzetani A; Havelock T; Maher TM; Molyneaux PL; Thorley AJ; Tetley TD; Warner JA; Packham G; Ganesan A; Skipp PJ; Marshall BJ; Richeldi L; Sime PJ; O'Reilly KMA; Davies DE
Oncotarget; 2017 Jul; 8(30):48737-48754. PubMed ID: 28467787
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of EC-SOD expression in aging lung fibroblasts: Role of histone acetylation.
Roman J; Zhu J; Ritzenthaler JD; Zelko IN
Free Radic Biol Med; 2017 Nov; 112():212-223. PubMed ID: 28757400
[TBL] [Abstract][Full Text] [Related]
15. Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option.
Korfei M; Mahavadi P; Guenther A
Cells; 2022 May; 11(10):. PubMed ID: 35626663
[TBL] [Abstract][Full Text] [Related]
16. Telomerase and telomere length in pulmonary fibrosis.
Liu T; Ullenbruch M; Young Choi Y; Yu H; Ding L; Xaubet A; Pereda J; Feghali-Bostwick CA; Bitterman PB; Henke CA; Pardo A; Selman M; Phan SH
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):260-8. PubMed ID: 23526226
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-29c regulates apoptosis sensitivity via modulation of the cell-surface death receptor, Fas, in lung fibroblasts.
Matsushima S; Ishiyama J
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1050-L1061. PubMed ID: 27765762
[TBL] [Abstract][Full Text] [Related]
18. Regulation of fibroblast Fas expression by soluble and mechanical pro-fibrotic stimuli.
Dodi AE; Ajayi IO; Chang C; Beard M; Ashley SL; Huang SK; Thannickal VJ; Tschumperlin DJ; Sisson TH; Horowitz JC
Respir Res; 2018 May; 19(1):91. PubMed ID: 29747634
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis.
Korfei M; Skwarna S; Henneke I; MacKenzie B; Klymenko O; Saito S; Ruppert C; von der Beck D; Mahavadi P; Klepetko W; Bellusci S; Crestani B; Pullamsetti SS; Fink L; Seeger W; Krämer OH; Guenther A
Thorax; 2015 Nov; 70(11):1022-32. PubMed ID: 26359372
[TBL] [Abstract][Full Text] [Related]
20. Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis.
Coward WR; Watts K; Feghali-Bostwick CA; Jenkins G; Pang L
Mol Cell Biol; 2010 Jun; 30(12):2874-86. PubMed ID: 20404089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
